Gerard Zalcman MD, PhD

Gerard Zalcman, MD, Ph.D. is a Professor of Pulmonology, Universite Paris Cite; Chair, Thoracic Oncology Department, Bichat Hospital, Assistance Publique-Hopitaux de Paris; Medical Director, Institute of Cancer AP-HP. Nord, Paris, France Gerard Zalcman, MD, Ph.D., is a full professor of Pulmonology at Universite Paris Cite, Paris, France, and chairs the Thoracic Oncology Department of Bichat Hospital, at Assistance Publique-Hopitaux de Paris. He serves as medical director of the Institute of Cancer AP-HP. Nord. He is the senior author of the three randomized trials published in Lancet and Lancet Oncol journals, which established the current standard treatments for mesothelioma, either pemetrexed-based chemotherapy plus bevacizumab, or the immunotherapy combo Nivolumab+ipilimumab.